First Aid Shot Therapy, Inc., a Burlingame, California-based consumer healthcare company focused on over-the-counter (OTC) therapies in liquid ‘shot’ (40ml / 1.35oz.) form, completed a Series A financing round.
The round, whose amount was not disclosed, was led by new investor Sofinnova Ventures.
The company intends to use the funds to support the U.S. product launch beginning in the summer of 2013.
Led by Mary Page Platerink, Founder and Chief Executive Officer, and co-founded by Professor Jay Pasricha, M.D., Professor of Medicine at Johns Hopkins Medicine, First Aid Shot Therapy offers OTC pharmaceutical based single serve liquids that meet the applicable OTC monograph and are intended to treat everyday conditions such as pain and upset stomach.
The company is also developing additional products aimed at a broad range of consumer needs and will be also launched.